Systematic capture of the patient perspective can inform the development of new cancer
therapies. Patient-reported outcomes (PROs) are commonly included in cancer clinical trials; …

Tremendous progress in treatment and outcomes has been achieved across the whole
range of haematological malignancies in the past two decades. Although cure rates for …

The next decade in cancer therapy will be marked by the expansion of immunotherapies,
namely immune checkpoint inhibitors. The increasing number and combination of …

Despite the high toxicity rates observed with some checkpoint inhibitor-based combination
therapies, these combinations will likely become the new paradigm for the management of …

Background Combining targeted agents and endocrine therapy (ET) improves outcomes in
hormone receptor-positive metastatic breast cancer patients but increases the risk of …

Abstract Since December, 2019, a 2019 novel coronavirus disease (COVID-19) infected by
the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in Wuhan …

Alopecia areata (AA) is an organ-restricted autoimmune disease that mainly affects the hair
follicle (HF). Several findings support a key primary effector role of CD8+ T cells in the …

Hintergrund Pflegeforschung ist eine wesentliche Komponente bei der Verbesserung der
Versorgung onkologisch erkrankter Menschen. Da der Forschungsbedarf hoch ist und …

Lapatinib (LAP) is an orally administered dual ErbB1 and ErbB2 tyrosine kinase inhibitor for
ErbB2-positive breast tumours, but is associated with diarrhoea. Incidence of lapatinib …

We report a case of a 37-year-old man with metastatic differentiated thyroid carcinoma,
previously submitted to total thyroidectomy, radio-iodine therapy and lung metastasectomy …